Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Sep;94(3):911–918. doi: 10.1172/JCI117455

Cross-fertilization among fields: a seminal event in the progress of biomedical research.

J A Berzofsky 1
PMCID: PMC295121  PMID: 8083374

Full text

PDF
911

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berzofsky J. A. Antigenic peptide interaction with MHC molecules: implications for the design of artificial vaccines. Semin Immunol. 1991 Jul;3(4):203–216. [PubMed] [Google Scholar]
  2. Berzofsky J. A., Cease K. B., Cornette J. L., Spouge J. L., Margalit H., Berkower I. J., Good M. F., Miller L. H., DeLisi C. Protein antigenic structures recognized by T cells: potential applications to vaccine design. Immunol Rev. 1987 Aug;98:9–52. doi: 10.1111/j.1600-065x.1987.tb00518.x. [DOI] [PubMed] [Google Scholar]
  3. Cease K. B., Berzofsky J. A. Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development. Annu Rev Immunol. 1994;12:923–989. doi: 10.1146/annurev.iy.12.040194.004423. [DOI] [PubMed] [Google Scholar]
  4. Comroe J. H., Jr, Dripps R. D. Scientific basis for the support of biomedical science. Science. 1976 Apr 9;192(4235):105–111. doi: 10.1126/science.769161. [DOI] [PubMed] [Google Scholar]
  5. Good M. F., Berzofsky J. A., Miller L. H. The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development. Annu Rev Immunol. 1988;6:663–688. doi: 10.1146/annurev.iy.06.040188.003311. [DOI] [PubMed] [Google Scholar]
  6. Lerner R. A., Benkovic S. J., Schultz P. G. At the crossroads of chemistry and immunology: catalytic antibodies. Science. 1991 May 3;252(5006):659–667. doi: 10.1126/science.2024118. [DOI] [PubMed] [Google Scholar]
  7. doi: 10.1172/JCI116990. [DOI] [PMC free article] [Google Scholar]
  8. Smith C. A., Farrah T., Goodwin R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 1994 Mar 25;76(6):959–962. doi: 10.1016/0092-8674(94)90372-7. [DOI] [PubMed] [Google Scholar]
  9. Yanuck M., Carbone D. P., Pendleton C. D., Tsukui T., Winter S. F., Minna J. D., Berzofsky J. A. A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells. Cancer Res. 1993 Jul 15;53(14):3257–3261. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES